Skip to main content

What the FDA labels say about taking them together

Erythromycin and fluvastatin

Fluvastatin's FDA label of April 21, 2025 names erythromycin in its warnings and precautions section; erythromycin's label does not name fluvastatin itself but warns about its class (Statins). The fluvastatin label: “The risk of myopathy and/or rhabdomyolysis with statins is increased with concurrent therapy with cyclosporine, erythromycin, fibrates or niacin.”

Check it at the source: the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.); the fluvastatin FDA label on DailyMed (effective April 21, 2025, Teva Pharmaceuticals USA, Inc.).

What does the erythromycin label say about fluvastatin?

Erythromycin's label does not name fluvastatin itself; it warns about its class (Statins):

Erythromycin label, contraindications

Erythromycin is contraindicated in patients taking terfenadine, astemizole, pimozide, or cisapride. (See PRECAUTIONS - Drug Interactions .) Do not use erythromycin concomitantly with HMG CoA reductase inhibitors (statins) that are extensively metabolized by CYP 3A4 (lovastatin or simvastatin), due to the increased risk of myopathy, including rhabdomyolysis.

Erythromycin label, contraindications

Do not use erythromycin concomitantly with HMG CoA reductase inhibitors (statins) that are extensively metabolized by CYP 3A4 (lovastatin or simvastatin), due to the increased risk of myopathy, including rhabdomyolysis.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

What does the fluvastatin label say about erythromycin?

Fluvastatin label, warnings and precautions

The risk of myopathy and/or rhabdomyolysis with statins is increased with concurrent therapy with cyclosporine, erythromycin, fibrates or niacin.

Source: FDA drug label (Fluvastatin), Teva Pharmaceuticals USA, Inc., effective April 21, 2025 (SPL set aad8b373-0aec-4efb-8e61-3d8114b31127), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

38Erythromycin generic labelers
4Fluvastatin generic labelers
ErythromycinFluvastatin
Labeled forBacterial infections, AcneHigh cholesterol
Boxed warningNoNo
Pharmacy cost (NADAC)$1.96 per tablet 250 mg tablet$2.88 per tablet 80 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?